-
First COVID-19 treatment authorised for use in the EU
First COVID-19 treatment authorised for use in the EU
-
First COVID-19 treatment authorised for use in the EU
First COVID-19 treatment authorised for use in the EU
The European Commission has granted a conditional marketing authorisation for Veklury (remdesivir), for the treatment of COVID-19 in adults and adolescents with pneumonia who require supplemental oxygen.
-
International regulators provide guiding principles for COVID-19 clinical trials
International regulators provide guiding principles for COVID-19 clinical trials
-
International regulators provide guiding principles for COVID-19 clinical trials
International regulators provide guiding principles for COVID-19 clinical trials
EMA has endorsed a joint statement on prioritisation of COVID-19 clinical trials published by the International Coalition of Medicines Regulatory Authorities (ICMRA) committing to step up global collaboration to facilitate and expedite the development and evaluation of therapeutics, diagnostics and vaccines against COVID-19.
-
Emer Cooke nominated as new EMA Executive Director
Emer Cooke nominated as new EMA Executive Director
-
Emer Cooke nominated as new EMA Executive Director
Emer Cooke nominated as new EMA Executive Director
The EMA Management Board has nominated Emer Cooke as the new Executive Director of the Agency. At an extraordinary virtual session, the Board selected Emer Cooke from a shortlist of candidates created by the European Commission.
-
COVID-19: latest updates
COVID-19: latest updates
-
COVID-19: latest updates
COVID-19: latest updates
Keep up to date with the latest information from EMA on the COVID-19 pandemic.
